DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+13.83%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$421M
AUM Growth
+$421M
(+25%)
Cap. Flow
+$56.4M
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
50.23%
Holding
96
New
22
Increased
24
Reduced
22
Closed
7
Top Buys
| 1 |
Nurix Therapeutics
NRIX
|
$9.52M |
| 2 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$7.59M |
| 3 |
Revolution Medicines
RVMD
|
$5.91M |
| 4 |
Protalix BioTherapeutics
PLX
|
$5.37M |
| 5 |
Adicet Bio
ACET
|
$4.02M |
Top Sells
| 1 |
Cassava Sciences
SAVA
|
$3.07M |
| 2 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$2.9M |
| 3 |
AGTC
Applied Genetic Technologies Corporation
AGTC
|
$2.4M |
| 4 |
Neuronetics
STIM
|
$2.35M |
| 5 |
Neurocrine Biosciences
NBIX
|
$1.8M |
Sector Composition
| 1 | Healthcare | 90.83% |
